Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against ischaemic stroke
Open accessThe DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
Stroke remains one of the most common causes of death and disability worldwide. Several preclinical studies demonstrated that the brain can be effectively protected against ischaemic stroke by two seemingly distinct treatments: remote ischaemic conditioning (RIC), involving cycles of ischaemia/reperfusion applied to a peripheral organ or tissue, or by systemic administration of glucagon-like-peptide-1 (GLP-1) receptor (GLP-1R) agonists. The mechanisms underlying RIC- and GLP-1-induced neuroprotection are not completely understood. In this study, we tested the hypothesis that GLP-1 mediates neuroprotection induced by RIC and investigated the effect of GLP-1R activation on cerebral blood vessels, as a potential mechanism of GLP-1-induced protection against ischaemic stroke. A rat model of ischaemic stroke (90 min of middle cerebral artery occlusion followed by 24-h reperfusion) was used. RIC was induced by 4 cycles of 5 min left hind limb ischaemia interleaved with 5-min reperfusion periods. RIC markedly (by ~ 80%) reduced the cerebral infarct size and improved the neurological score. The neuroprotection established by RIC was abolished by systemic blockade of GLP-1R with a specific antagonist Exendin(9–39). In the cerebral cortex of GLP-1R reporter mice, ~ 70% of cortical arterioles displayed GLP-1R expression. In acute brain slices of the rat cerebral cortex, activation of GLP-1R with an agonist Exendin-4 had a strong dilatory effect on cortical arterioles and effectively reversed arteriolar constrictions induced by metabolite lactate or oxygen and glucose deprivation, as an ex vivo model of ischaemic stroke. In anaesthetised rats, Exendin-4 induced lasting increases in brain tissue PO 2, indicative of increased cerebral blood flow. These results demonstrate that neuroprotection against ischaemic stroke established by remote ischaemic conditioning is mediated by a mechanism involving GLP-1R signalling. Potent dilatory effect of GLP-1R activation on cortical arterioles suggests that the neuroprotection in this model is mediated via modulation of cerebral blood flow and improved brain perfusion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GLP-1RAs may also offer neuroprotection by improving/maintaining CBF in the regions surrounding the affected brain area [69].”
From Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms (2022) · cites this paper as [69]
In the citing paper
“In a recent in vivo/ex vivo study using a rat model of ischemic stroke induced by MCAO, systemic administration of exendin-4 was found to be neuroprotective via its vasodilatory action on cortical arterioles and improved CBF [69].”
From Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms (2022) · cites this paper as [69]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Johnson, C. O., Nguyen, M., Roth, G. A., Nichols, E., Alam, T., Abate, D., Abd-Allah, F., Abdelalim, A., Abraha, H. N., Abu-Rmeileh, N. M., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30034-1 · Cited by 3,264
A molecular atlas of cell types and zonation in the brain vasculature
Vanlandewijck, M., He, L., Mäe, M. A., Andrae, J., Ando, K., Del Gaudio, F., Nahar, K., Lebouvier, T., Laviña, B., Gouveia, L., et al. (2018) · Nature · doi:10.1038/nature25739 · Cited by 1,892 · cited 1×
“These data are fully consistent with the results of single-cell RNA sequencing of brain vasculature [80].”
ResultGlucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868 · cited 1×
“in the gut and also by the groups of specialized CNS neurons located in the brainstem [35, 66].”
BackgroundSelf-citationLactate in the brain: from metabolic end-product to signalling molecule
Magistretti, P. J., & Allaman, I. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.19 · Cited by 1,298 · cited 2×
“Lactate was used as a constricting agent because the release of this metabolite markedly increases in hypoxic and ischaemic conditions [43, 44, 57].”
MethodMyocardial ischaemia–reperfusion injury and cardioprotection in perspective
Heusch, G. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0403-y · Cited by 1,234 · cited 1×
“This well-characterized phenomenon is called remote ischaemic conditioning (RIC) [23, 31, 33, 39, 47].”
BackgroundBan, K., Noyan-Ashraf, M. H., Hoefer, J., Bolz, S.-S., Drucker, D. J., & Husain, M. (2008) · Circulation · doi:10.1161/circulationaha.107.739938 · Cited by 1,057
Evolving Therapies for Myocardial Ischemia/Reperfusion Injury
Ibáñez, B., Heusch, G., Ovize, M., & Van de Werf, F. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.032 · Cited by 1,009 · cited 1×
“This well-characterized phenomenon is called remote ischaemic conditioning (RIC) [23, 31, 33, 39, 47].”
BackgroundGlucagon-like peptide-1 receptor is involved in learning and neuroprotection
During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., Bland, R. J., Klugmann, M., Banks, W. A., Drucker, D. J., et al. (2003) · Nature Medicine · doi:10.1038/nm919 · Cited by 851 · cited 1×
“However, the mechanisms underlying GLP-1R-mediated neuroprotection remain largely unknown [19, 59].”
BackgroundChen, W.-B., Vasseur, L., Zhang, S.-Q., Zhang, H.-F., Mao, J., Liu, T.-S., Zhou, X.-Y., Wang, X., Zhang, J., You, M.-S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-67050-1 · Cited by 749
Li, Y., Perry, T., Kindy, M. S., Harvey, B. K., Tweedie, D., Holloway, H. W., Powers, K., Shen, H., Egan, J. M., Sambamurti, K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806720106 · Cited by 589 · cited 1×
“There is evidence that treatment with GLP-1R agonists increases GLP1R expression, increases the level of the neurotrophic factor BDNF, protects the blood–brain barrier through MMP-9 regulation, decreases microglial activation, oxidative stress and the release of apoptotic factors [41, 48, 50, 51, 78, 85].”
BackgroundAstrocytes mediate neurovascular signaling to capillary pericytes but not to arterioles
Mishra, A., Reynolds, J. P., Chen, Y., Gourine, A. V., Rusakov, D. A., & Attwell, D. (2016) · Nature Neuroscience · doi:10.1038/nn.4428 · Cited by 543 · cited 1×
“Vessels in brain slices are lacking tone and are typically fully dilated (due to the absence of the perfusion pressure), therefore, studies of cerebrovascular responses ex vivo require the application of the constricting agents [65].”
BackgroundSelf-citationCork, S. C., Richards, J. E., Holt, M. K., Gribble, F. M., Reimann, F., & Trapp, S. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.07.008 · Cited by 478 · cited 3×
“It is also conceivable that RIC stimulates the release of GLP-1 within the brain by the preproglucagon neurons that reside in the brainstem and have projections to the forebrain [16, 40, 53].”
BackgroundMethodSelf-citationRichards, P., Parker, H. E., Adriaenssens, A. E., Hodgson, J. M., Cork, S. C., Trapp, S., Gribble, F. M., & Reimann, F. (2014) · Diabetes · doi:10.2337/db13-1440 · Cited by 472
Self-citationGraaf, C. D., Donnelly, D., Wootten, D., Lau, J., Sexton, P. M., Miller, L. J., Ahn, J.-M., Liao, J., Fletcher, M. M., Yang, D., et al. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011395 · Cited by 403 · cited 1×
“That cAMP mediates the effects of a GLP-1 analogue is not surprising considering that GLP-1R is a well-characterized Gs-coupled receptor [17].”
BackgroundJin, S. ‐. C., Han, V. K. M., Simmons, J. G., Towle, A. C., Lauder, J. M., & Lund, P. K. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902710405 · Cited by 335 · cited 1×
“It is also conceivable that RIC stimulates the release of GLP-1 within the brain by the preproglucagon neurons that reside in the brainstem and have projections to the forebrain [16, 40, 53].”
BackgroundSchoenwaelder, S. M., Darbousset, R., Cranmer, S. L., Ramshaw, H. S., Orive, S. L., Sturgeon, S., Yuan, Y., Yao, Y., Krycer, J. R., Woodcock, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms16125 · Cited by 293
Kerendi, F., Kin, H., Halkos, M. E., Jiang, R., Zatta, A. J., Zhao, Z. –., Guyton, R. A., & Vinten–Johansen, J. (2005) · Basic Research in Cardiology · doi:10.1007/s00395-005-0539-2 · Cited by 292
Seners, P., Turc, G., Maïer, B., Mas, J.-L., Oppenheim, C., & Baron, J.-C. (2016) · Stroke · doi:10.1161/strokeaha.116.014181 · Cited by 290
Hougaard, K. D., Hjort, N., Zeidler, D., Sørensen, L., Nørgaard, A., Hansen, T. M., von Weitzel-Mudersbach, P., Simonsen, C. Z., Damgaard, D., Gottrup, H., et al. (2014) · Stroke · doi:10.1161/strokeaha.113.001346 · Cited by 283
Coronary microvascular obstruction: the new frontier in cardioprotection
Heusch, G. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-019-0756-8 · Cited by 253 · cited 1×
“The importance of preserving microvascular flow in the context of cardioprotection against myocardial ischaemia/reperfusion injury had been recently highlighted [32].”
BackgroundRemote ischaemic conditioning—a new paradigm of self-protection in the brain
Hess, D. C., Blauenfeldt, R. A., Andersen, G., Hougaard, K. D., Hoda, M. N., Ding, Y., & Ji, X. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.223 · Cited by 230 · cited 1×
“This well-characterized phenomenon is called remote ischaemic conditioning (RIC) [23, 31, 33, 39, 47].”
BackgroundMastitskaya, S., Marina, N., Gourine, A., Gilbey, M. P., Spyer, K. M., Teschemacher, A. G., Kasparov, S., Trapp, S., Ackland, G. L., & Gourine, A. V. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs212 · Cited by 227
Self-citationHolt, M. K., Richards, J. E., Cook, D. R., Brierley, D. I., Williams, D. L., Reimann, F., Gribble, F. M., & Trapp, S. (2019) · Diabetes · doi:10.2337/db18-0729 · Cited by 212 · cited 1×
“in the gut and also by the groups of specialized CNS neurons located in the brainstem [35, 66].”
BackgroundSelf-citationLønborg, J., Kelbæk, H., Vejlstrup, N., Bøtker, H. E., Kim, W. Y., Holmvang, L., Jørgensen, E., Helqvist, S., Saunamäki, K., Terkelsen, C. J., et al. (2012) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.112.968388 · Cited by 210 · cited 1×
“Indeed, exenatide (synthetic Ex4) had been shown to reduce the myocardial injury in patients with myocardial infarction [54], although the results of a recent clinical trial studying the individual effects of RIC, exenatide, and their combination (COMBAT-MI trial) showed no effect of these treatments on infarct size […”
ResultAstrocytes monitor cerebral perfusion and control systemic circulation to maintain brain blood flow
Marina, N., Christie, I. N., Korsak, A., Doronin, M., Brazhe, A., Hosford, P. S., Wells, J. A., Sheikhbahaei, S., Humoud, I., Paton, J. F. R., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13956-y · Cited by 206 · cited 1×
“Brain tissue PO2 was recorded in the left cerebral cortex using optical probes (250 μm tip diameter; OxyLite system; Oxford Optronix) placed ~ 2 mm below the surface of the brain, as described previously [58].”
MethodSelf-citationTeramoto, S., Miyamoto, N., Yatomi, K., Tanaka, Y., Oishi, H., Arai, H., Hattori, N., & Urabe, T. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.51 · Cited by 201 · cited 2×
“Experimental studies conducted in gerbils, mice and rats demonstrated that GLP-1 receptor (GLP-1R) agonists Exendin 4 (Ex4), liraglutide or semaglutide, administered either systemically or centrally, are highly effective in protecting the brain against ischaemic stroke induced by bilateral carotid artery occlusion or…”
BackgroundProtecting the ischaemic penumbra as an adjunct to thrombectomy for acute stroke
Baron, J.-C. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0002-2 · Cited by 197 · cited 2×
“Indeed, maintaining/ restoring blood supply in the penumbra has been shown to reduce the size and severity of cerebral infarcts [4].”
BackgroundPreproglucagon neurons project widely to autonomic control areas in the mouse brain
Llewellyn-Smith, I. J., Reimann, F., Gribble, F. M., & Trapp, S. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.023 · Cited by 194 · cited 2×
“It is also conceivable that RIC stimulates the release of GLP-1 within the brain by the preproglucagon neurons that reside in the brainstem and have projections to the forebrain [16, 40, 53].”
BackgroundSelf-citationEngland, T. J., Hedstrom, A., O’Sullivan, S., Donnelly, R., Barrett, D. A., Sarmad, S., Sprigg, N., & Bath, P. M. (2017) · Stroke · doi:10.1161/strokeaha.116.016429 · Cited by 194
Cardioprotection by remote ischemic conditioning and its signal transduction
Kleinbongard, P., Skyschally, A., & Heusch, G. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1922-6 · Cited by 192
Gaspar, A., Lourenço, A. P., Pereira, M. Á., Azevedo, P., Roncon-Albuquerque, R., Marques, J., & Leite-Moreira, A. F. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0672-3 · Cited by 178 · cited 1×
“This well-characterized phenomenon is called remote ischaemic conditioning (RIC) [23, 31, 33, 39, 47].”
BackgroundВасильевна, Б. М., Barsukevich, V. C., Mastitskaya, S., Mrochek, A., Pernow, J., Sjöquist, P.-O. B., Ackland, G. L., Gourine, A. V., & Gourine, A. V. (2012) · Experimental Physiology · doi:10.1113/expphysiol.2012.064923 · Cited by 161 · cited 3×
“Our studies showed that these include sensory (afferent) innervation of the peripheral tissue undergoing RIC, autonomic parasympathetic (vagal) pathways, and the actions of an incretin hormone glucagonlike-peptide-1 (GLP-1), as a likely humoral mediator of RIC [5, 6, 62, 63].”
BackgroundSelf-citationSkyschally, A., Gent, S., Amanakis, G., Schulte, C., Kleinbongard, P., & Heusch, G. (2015) · Circulation Research · doi:10.1161/circresaha.117.306878 · Cited by 154 · cited 1×
“Previous studies on the mechanisms of RIC-induced cardioprotection against ischaemia/reperfusion injury suggested that RIC recruits interacting neuronal and humoral mechanisms [8, 24, 26, 52, 75].”
BackgroundGreen, B. D., Hand, K. V., Dougan, J. E., McDonnell, B. M., Cassidy, R. S., & Grieve, D. J. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.08.001 · Cited by 151 · cited 1×
“The vasodilatory effect of GLP-1 on the aorta was shown to be mediated through glucagon signalling, KATP channels, PKA phosphorylation [27, 30, 73] and increased NO production [3].”
BackgroundGourine, A. V., & Ackland, G. L. (2018) · Physiology · doi:10.1152/physiol.00041.2018 · Cited by 145
Self-citationHui, H., Farilla, L., Merkel, P., & Perfetti, R. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460863 · Cited by 143 · cited 1×
“Yet, there is also evidence that the lasting effects of GLP-1 may persist for some time even when the circulating levels of the hormone return back to the normal level [38].”
BackgroundGlucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning
Basalay, M. V., Mastitskaya, S., Mrochek, A., Ackland, G. L., del Arroyo, A. G., Sanchez, J., Sjoquist, P.-O., Pernow, J., Gourine, A. V., & Gourine, A. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw216 · Cited by 132
Self-citationVago-Splenic Axis in Signal Transduction of Remote Ischemic Preconditioning in Pigs and Rats
Lieder, H. R., Kleinbongard, P., Skyschally, A., Hagelschuer, H., Chilian, W. M., & Heusch, G. (2018) · Circulation Research · doi:10.1161/circresaha.118.313859 · Cited by 127 · cited 1×
“Previous studies on the mechanisms of RIC-induced cardioprotection against ischaemia/reperfusion injury suggested that RIC recruits interacting neuronal and humoral mechanisms [8, 24, 26, 52, 75].”
BackgroundGLP-1’s role in neuroprotection: a systematic review
Erbil, D., Eren, C. Y., Demirel, C., Küçüker, M. U., Solaroğlu, I., & Eser, H. Y. (2019) · Brain Injury · doi:10.1080/02699052.2019.1587000 · Cited by 126 · cited 2×
“Experimental studies conducted in gerbils, mice and rats demonstrated that GLP-1 receptor (GLP-1R) agonists Exendin 4 (Ex4), liraglutide or semaglutide, administered either systemically or centrally, are highly effective in protecting the brain against ischaemic stroke induced by bilateral carotid artery occlusion or…”
BackgroundRemote Ischemic Per-Conditioning: A Novel Therapy for Acute Stroke?
Hahn, C. D., Manlhiot, C., Schmidt, M. R., Nielsen, T. T., & Redington, A. N. (2011) · Stroke · doi:10.1161/strokeaha.111.622340 · Cited by 125
Osto, E., Doytcheva, P., Corteville, C., Bueter, M., Dörig, C., Stivala, S., Buhmann, H., Colin, S., Rohrer, L., Hasballa, R., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.011791 · Cited by 125
Pico, F., Lapergue, B., Ferrigno, M., Rosso, C., Meseguer, E., Chadenat, M., Bourdain, F., Obadia, M., Hirel, C., Duong, D. L., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.0326 · Cited by 123 · cited 1×
“Yet, clinical data show no major beneficial effect of RIC on stroke outcomes [68], although with some suggestion of reduced recurrent strokes with intracerebral artery stenosis treatment, and decreased stroke severity with carotid stenosis [69].”
BackgroundSpratt, N. J., Fernandez, J., Chen, M., Rewell, S. S. J., Cox, S., van Raay, L., Hogan, L., & Howells, D. W. (2006) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2006.01.020 · Cited by 121 · cited 1×
“The animals underwent surgery to allow transient middle cerebral artery occlusion (MCAO) to induce cerebral ischaemia, as an experimental model of stroke [76].”
MethodHyun Lee, C., Yan, B., Yoo, K., Choi, J. H., Kwon, S., Her, S., Sohn, Y., Hwang, I. K., Cho, J. H., Kim, Y., et al. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22596 · Cited by 118
Remote Ischemic Conditioning May Improve Outcomes of Patients With Cerebral Small-Vessel Disease
Wang, Y., Meng, R., Song, H., Liu, G., Yang, H., Cui, D., Zheng, L., Feng, W., Liebeskind, D. S., Fisher, M., et al. (2017) · Stroke · doi:10.1161/strokeaha.117.017691 · Cited by 118
Imaging pericytes and capillary diameter in brain slices and isolated retinae
Mishra, A., O'Farrell, F. M., Reynell, C., Hamilton, N. B., Hall, C. N., & Attwell, D. (2014) · Nature Protocols · doi:10.1038/nprot.2014.019 · Cited by 107
Bromage, D. I., Pickard, J. M. J., Rosselló, X., Ziff, O. J., Burke, N., Yellon, D. M., & Davidson, S. M. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw219 · Cited by 107 · cited 1×
“Powerful innate mechanisms of inter-organ protection are activated by remote ischaemic conditioning which can be established by cycles of ischaemia/reperfusion applied to an organ/tissue distant from the organ being protected [13].”
BackgroundSelf-citationEarly brain temperature elevation and anaerobic metabolism in human acute ischaemic stroke
Karaszewski, B., Wardlaw, J. M., Marshall, I., Cvoro, V., Wartolowska, K. A., Haga, K., Armitage, P., Bastin, M. E., & Dennis, M. S. (2008) · Brain · doi:10.1093/brain/awp010 · Cited by 96 · cited 2×
“Lactate was used as a constricting agent because the release of this metabolite markedly increases in hypoxic and ischaemic conditions [43, 44, 57].”
MethodChen, G., Thakkar, M., Robinson, C. P., & Doré, S. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00040 · Cited by 94
Hemichannel-mediated release of lactate
Karagiannis, A., Sylantyev, S., Hadjihambi, A., Hosford, P. S., Kasparov, S., & Gourine, A. V. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15611912 · Cited by 92 · cited 2×
“Lactate was used as a constricting agent because the release of this metabolite markedly increases in hypoxic and ischaemic conditions [43, 44, 57].”
MethodSelf-citationDavidson, S. M., Arjun, S., Basalay, M. V., Bell, R. M., Bromage, D. I., Bøtker, H. E., Carr, R. D., Cunningham, J., Ghosh, A. K., Heusch, G., et al. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0704-z · Cited by 89
Self-citationvan Geemen, D., Soares, A. L. F., Oomen, P. J. A., Driessen‐Mol, A., den Broek, M. W. J. T. J.-V., van den Bogaerdt, A. J., Bogers, A. J. J. C., Goumans, M., Baaijens, F. F., & Bouten, C. V. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149020 · Cited by 84
Васильевна, Б. М., Davidson, S. M., Gourine, A. V., & Yellon, D. M. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0684-z · Cited by 84
Self-citationVagal determinants of exercise capacity
Machhada, A., Trapp, S., Marina, N., Stephens, R. C. M., Whittle, J., Lythgoe, M. F., Kasparov, S., Ackland, G. L., & Gourine, A. V. (2017) · Nature Communications · doi:10.1038/ncomms15097 · Cited by 83 · cited 1×
“As we reasoned in our earlier publications [7, 25, 26, 63] and reported supporting evidence [1, 56], vagal tone decreases with age and could be severely diminished or even absent in many disease states, rendering many patients unable to recruit innate mechanisms of inter-organ protection.”
ResultSelf-citationSun, J., Li, T., Luan, Q., Deng, J., Li, Y., Li, Z., Dong, H., & Xiong, L. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.199 · Cited by 82 · cited 1×
“However, the mechanisms of RIC-induced neuroprotection are not fully understood and have been proposed to include reduction of astrogliosis, maintenance of blood–brain barrier integrity, the opening of KATP channels, prevention of let7a and miR-43 overexpression, and other mechanisms [15, 20, 48, 69, 70, 77, 82].”
BackgroundIdentifying the Source of a Humoral Factor of Remote (Pre)Conditioning Cardioprotection
Mastitskaya, S., Васильевна, Б. М., Hosford, P. S., Ramage, A. G., Gourine, A. V., & Gourine, A. V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150108 · Cited by 82 · cited 4×
“Our studies showed that these include sensory (afferent) innervation of the peripheral tissue undergoing RIC, autonomic parasympathetic (vagal) pathways, and the actions of an incretin hormone glucagonlike-peptide-1 (GLP-1), as a likely humoral mediator of RIC [5, 6, 62, 63].”
BackgroundSelf-citationCerebral Blood Flow and Brain Oxygenation in Rats Breathing Oxygen under Pressure
It, D., Luchakov, Y. I., Moskvin, A. N., Gutsaeva, D. R., Allen, B. W., Thalmann, E. D., & Piantadosi, C. A. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600110 · Cited by 77 · cited 2×
“perfusion [18], these data indicate that activation of GLP1Rs increases cerebral blood flow.”
BackgroundMethodBasalay, M. V., Davidson, S. M., & Yellon, D. M. (2019) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-019-06915-8 · Cited by 68
Self-citationYang, D. W., Nakajo, Y., Iihara, K., Kataoka, H., & Yanamoto, H. (2013) · Brain Research · doi:10.1016/j.brainres.2013.04.015 · Cited by 63
Neural Mechanisms of Cardioprotection
Gourine, A., & Gourine, A. V. (2014) · Physiology · doi:10.1152/physiol.00037.2013 · Cited by 62
Self-citationMarlet, I. R., Ölmestig, J. N. E., Vilsbøll, T., Rungby, J., & Kruuse, C. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12974 · Cited by 61 · cited 2×
“Experimental studies conducted in gerbils, mice and rats demonstrated that GLP-1 receptor (GLP-1R) agonists Exendin 4 (Ex4), liraglutide or semaglutide, administered either systemically or centrally, are highly effective in protecting the brain against ischaemic stroke induced by bilateral carotid artery occlusion or…”
Backgroundvan der Zijden, J. P., Bouts, M. J. R. J., Wu, O., Roeling, T. A. P., Bleys, R. L., van der Toorn, A., & Dijkhuizen, R. M. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600576 · Cited by 60
Kuroki, T., Tanaka, R., Shimada, Y., Yamashiro, K., Ueno, Y., Shimura, H., Urabe, T., & Hattori, N. (2016) · Stroke · doi:10.1161/strokeaha.116.012934 · Cited by 60
Remote Ischemic Conditioning as an Additional Treatment for Acute Ischemic Stroke
Landman, T. R. J., Schoon, Y., Warlé, M. C., de Leeuw, F., & Thijssen, D. H. J. (2019) · Stroke · doi:10.1161/strokeaha.119.025494 · Cited by 54
A meta-analysis of remote ischaemic conditioning in experimental stroke
Weir, P., Maguire, R., O’Sullivan, S. E., & England, T. J. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20924077 · Cited by 50 · cited 2×
“More than 40 preclinical studies demonstrated that RIC can protect the brain against ischaemic stroke [14, 49, 72, 84].”
BackgroundGedik, N., Kottenberg, E., Thielmann, M., Frey, U. H., Jakob, H. G., Peters, J., Heusch, G., & Kleinbongard, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-12833-2 · Cited by 47 · cited 1×
“Previous studies on the mechanisms of RIC-induced cardioprotection against ischaemia/reperfusion injury suggested that RIC recruits interacting neuronal and humoral mechanisms [8, 24, 26, 52, 75].”
BackgroundModulation of Cardiac Ventricular Excitability by GLP-1 (Glucagon-Like Peptide-1)
Ang, R., Mastitskaya, S., Hosford, P. S., Basalay, M., Specterman, M., Aziz, Q., Li, Y., Orini, M., Taggart, P., Lambiase, P. D., et al. (2018) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.118.006740 · Cited by 47
Self-citationHan, F., Hou, N., Liu, Y., Huang, N., Pan, R., Zhang, X., Mao, E., & Sun, X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109537 · Cited by 47 · cited 1×
“The vasodilatory effect of GLP-1 on the aorta was shown to be mediated through glucagon signalling, KATP channels, PKA phosphorylation [27, 30, 73] and increased NO production [3].”
BackgroundKitagawa, K., Saito, M., Ishizuka, K., & Shimizu, S. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2017.09.068 · Cited by 44 · cited 1×
“The conclusions of this study are also supported by the recent evidence obtained in rodent models showing a marked reduction of cerebral blood flow after MCAO and improved collateral circulation in response to RIC [46, 55].”
ResultRemote postconditioning ameliorates stroke damage by preventing let-7a and miR-143 up-regulation
Vinciguerra, A., Cepparulo, P., Anzilotti, S., Cuomo, O., Valsecchi, V., Amoroso, S., Annunziato, L., & Pignataro, G. (2020) · Theranostics · doi:10.7150/thno.48135 · Cited by 43 · cited 1×
“However, the mechanisms of RIC-induced neuroprotection are not fully understood and have been proposed to include reduction of astrogliosis, maintenance of blood–brain barrier integrity, the opening of KATP channels, prevention of let7a and miR-43 overexpression, and other mechanisms [15, 20, 48, 69, 70, 77, 82].”
Backgrounddel Blanco, B. G., Otaegui, I., Rodríguez-Palomares, J. F., Bayés‐Genís, A., Fernández‐Nofrerías, E., Vilalta, V., Carrillo, X., Ibáñez, B., Worner, F., Casanova, J., et al. (2021) · Basic Research in Cardiology · doi:10.1007/s00395-021-00842-2 · Cited by 40 · cited 1×
“Indeed, exenatide (synthetic Ex4) had been shown to reduce the myocardial injury in patients with myocardial infarction [54], although the results of a recent clinical trial studying the individual effects of RIC, exenatide, and their combination (COMBAT-MI trial) showed no effect of these treatments on infarct size […”
ResultZhai, R., Xu, H., Hu, F., Wu, J., Kong, X., & Sun, X. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15059 · Cited by 39
Ripley, A., Jeffers, M. S., McDonald, M. W., Montroy, J. R., Dykes, A., Fergusson, D. A., Silasi, G., Lalu, M. M., & Corbett, D. (2021) · Translational Stroke Research · doi:10.1007/s12975-020-00882-1 · Cited by 38 · cited 2×
“More than 40 preclinical studies demonstrated that RIC can protect the brain against ischaemic stroke [14, 49, 72, 84].”
BackgroundSélley, E., Kun, S., Szijártó, I., Kertész, M., Wittmann, I., & Molnár, G. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-101794 · Cited by 35 · cited 1×
“The vasodilatory effect of GLP-1 on the aorta was shown to be mediated through glucagon signalling, KATP channels, PKA phosphorylation [27, 30, 73] and increased NO production [3].”
BackgroundHolt, M. K., Cook, D. R., Brierley, D. I., Richards, J. E., Reimann, F., Gourine, A. V., Marina, N., & Trapp, S. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101024 · Cited by 35
Self-citationMa, J., Ma, Y., Shuaib, A. M., & Winship, I. R. (2020) · Scientific Reports · doi:10.1038/s41598-020-69122-8 · Cited by 33 · cited 1×
“The conclusions of this study are also supported by the recent evidence obtained in rodent models showing a marked reduction of cerebral blood flow after MCAO and improved collateral circulation in response to RIC [46, 55].”
ResultAckland, G. L., Whittle, J., Toner, A., Machhada, A., del Arroyo, A. G., Sciuso, A., Jenkins, N., Dyson, A., Struthers, R., Sneyd, J. R., et al. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001606 · Cited by 32 · cited 1×
“As we reasoned in our earlier publications [7, 25, 26, 63] and reported supporting evidence [1, 56], vagal tone decreases with age and could be severely diminished or even absent in many disease states, rendering many patients unable to recruit innate mechanisms of inter-organ protection.”
Self-citationGregori-Pla, C., Blanco, I., Camps‐Renom, P., Zirak, P., Serra, I., Cotta, G., Maruccia, F., Prats‐Sánchez, L., Domeño, A. M., Busch, D. R., et al. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09226-y · Cited by 30 · cited 1×
“Dilation of cortical arterioles induced by GLP-1R activation is likely to lessen the impact of the neurotoxic effects associated with impaired cerebral perfusion in stroke, as early improved perfusion is beneficial for better functional outcomes [28].”
BackgroundCheng, X. Y., Zhao, H., Yan, F., Tao, Z., Wang, R., Han, Z., Li, G., Luo, Y., & Ji, X. (2018) · Brain Research · doi:10.1016/j.brainres.2018.02.019 · Cited by 27 · cited 1×
“However, the mechanisms of RIC-induced neuroprotection are not fully understood and have been proposed to include reduction of astrogliosis, maintenance of blood–brain barrier integrity, the opening of KATP channels, prevention of let7a and miR-43 overexpression, and other mechanisms [15, 20, 48, 69, 70, 77, 82].”
BackgroundВасильевна, Б. М., Wiart, M., Chauveau, F., Dumot, C., Léon, C., Amaz, C., Bolbos, R. I., Cash, D., Kim, E., Mechtouff, L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-74046-4 · Cited by 26 · cited 2×
“interleaved with 5-min reperfusion periods [10, 29], applied using an inflatable 12-mm cuff (IVM, USA).”
BackgroundMethodSelf-citationPurroy, F. F., García, C., Mauri, G., Pereira, C., Torres-Querol, C., Vázquez-Justes, D., Pascual, M. V., Vena, A. B., & Arqué, G. (2020) · BMC Neurology · doi:10.1186/s12883-020-01836-8 · Cited by 23 · cited 2×
“However, the mechanisms of RIC-induced neuroprotection are not fully understood and have been proposed to include reduction of astrogliosis, maintenance of blood–brain barrier integrity, the opening of KATP channels, prevention of let7a and miR-43 overexpression, and other mechanisms [15, 20, 48, 69, 70, 77, 82].”
BackgroundJin, J., Kang, H.-M., Jung, J., Jeong, J.-W., & Park, C. (2014) · NeuroReport · doi:10.1097/wnr.0000000000000046 · Cited by 21
Verouhis, D., Saleh, N., Settergren, M., Sörensson, P., Gourine, A. V., & Pernow, J. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.09.061 · Cited by 19 · cited 1×
“In our previously proposed model of RIC-induced cardioprotection, we suggested that cycles of remote ischaemia/ reperfusion activate tissue nociceptors [5] that project to the CNS, leading to activation of a specific group of vagal preganglionic neurons [62] that innervate the gut [63], and upon activation stimulate t…”
BackgroundSelf-citationEffects of Remote Ischemic Conditioning on Cerebral Hemodynamics in Ischemic Stroke
Chen, Q., Yan, X., Jin, H., Zhang, R., He, Y., Sun, X., Zhang, Y., Guo, Z., & Yang, Y. R. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s231944 · Cited by 18 · cited 1×
“However, the mechanisms of RIC-induced neuroprotection are not fully understood and have been proposed to include reduction of astrogliosis, maintenance of blood–brain barrier integrity, the opening of KATP channels, prevention of let7a and miR-43 overexpression, and other mechanisms [15, 20, 48, 69, 70, 77, 82].”
BackgroundJung, H. S., Tsai, H., Wong, D., Germany, C., Kahn, S., Kim, Y., Aikawa, A. S., Desai, D., Rodgers, G., Bradley, A. J., et al. (2015) · Journal of Visualized Experiments · doi:10.3791/52711 · Cited by 13
Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
Brandli, A. A. (2015) · Journal of Visualized Experiments · doi:10.3791/52213 · Cited by 10
Reply: Glucagon-like peptide-1 mediates cardioprotection by remote ischaemic conditioning
Васильевна, Б. М., Mastitskaya, S., Mrochek, A., Ackland, G. L., del Arroyo, A. G., Sanchez, J., Sjöquist, P.-O. B., Pernow, J., Gourine, A. V., & Gourine, A. V. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw238 · Cited by 9 · cited 1×
“As we reasoned in our earlier publications [7, 25, 26, 63] and reported supporting evidence [1, 56], vagal tone decreases with age and could be severely diminished or even absent in many disease states, rendering many patients unable to recruit innate mechanisms of inter-organ protection.”
Self-citationSearching myocardial rescue through intermittent upper arm occlusion and lizard saliva
Bøtker, H. E. (2021) · Basic Research in Cardiology · doi:10.1007/s00395-021-00843-1 · Cited by 2 · cited 1×
“However, as it was highlighted [11] in that study neither the dose given, nor the plasma concentration of exenatide were known to determine the bioavailability of the drug at the time of treatment.”
Background
Cited by
Kopp, K. O., Glotfelty, E. J., Li, Y., & Greig, N. H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106550 · Cited by 298
Trapp, S., & Brierley, D. I. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15638 · Cited by 154
Self-citationIncretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease
Nowell, J., Blunt, E., & Edison, P. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01792-4 · Cited by 136
Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions
Bhalla, S., Mehan, S., Khan, A., & Rehman, M. U. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104896 · Cited by 108
Vergès, B., Aboyans, V., Angoulvant, D., Boutouyrie, P., Cariou, B., Hyafil, F., Mohammedi, K., & Amarenco, P. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01686-3 · Cited by 72
“There are currently two ongoing randomized, phase II studies (NCT02829502; NCT03287076) performed in patients with ischemic stroke to evaluate the impact of exenatide therapy on various mechanistic outcomes such as CBF velocity, endothelial function, inflammation, and post-stroke hyperglycemia.”
BackgroundInfluential
Metadata
- Authors
- Nizari, S., Basalay, M., Chapman, P., Korte, N., Korsak, A., Christie, I. N., Theparambil, S. M., Davidson, S. M., Reimann, F., Trapp, S., Yellon, D. M., & Gourine, A. V.
- Affiliations
- University College London (GB)
- University of Cambridge (GB)
- Corresponding author
- Gourine, Alexander V.
- ORCID
- Venue
- Basic Research in Cardiology
- Published
- 2021-05-03
- Volume
- 116
- Issue
- 1
- Pages
- 32-32
- ISSN
- 0003-9217 (ISSN-L)
- 0300-8428
- 1435-1803
- PMC
- PMC8093159
- OpenAlex
- W3159867433
- Cited by
- 77
- References
- 91
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 15 · 2023: 9 · 2022: 20 · 2021: 1
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Basic Research in Cardiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Lancaster EPrints (Lancaster University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Apollo
- Apollo (cc-by)
- Funders
- Wellcome Trust (200893)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- GLP-1 receptor, remote ischemic conditioning, ischemic stroke, neuroprotection, cerebral blood flow, cerebral arterioles, vasodilation, exendin-4, exendin-9-39, middle cerebral artery occlusion, oxygen-glucose deprivation, cerebral oxygenation, GLP-1 receptor agonists
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Ischemic Stroke, Animals, Arterioles, Cerebrovascular Circulation, Disease Models, Animal, Hindlimb, Male, Peptide Fragments, Regional Blood Flow, Vasodilation, Vasodilator Agents, Rats, Sprague-Dawley, Neuroprotective Agents, Ischemic Preconditioning, Infarction, Middle Cerebral Artery, Rats, Incretins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.